Tag Archives: University of Arizona’s College of Medicine

trauma

Abrazo Health Announces New Trauma Medical Director

Abrazo Health, the second largest health care delivery system in Arizona, has announced Dr. Christopher Salvino as West Valley Hospital’s new Trauma Medical Director. Dr. Salvino is an accomplished trauma surgeon with experience in leading American College of Surgeons (ACS)-verified trauma centers.

As Trauma Medical Director (TMD), Dr. Salvino will be responsible for the development of the trauma program at West Valley Hospital. Specifically, he will develop a trauma service inclusive of a specialist on-call panel, treatment protocols, and oversee the hospital’s peer review and performance improvement process.  Additionally, he will provide leadership in the development of the regional Trauma System by continuing to serve on national, regional and local committees.

“I am thrilled to be part of the Abrazo team in developing a modern, high-quality and professional Trauma service at West Valley Hospital.” said Dr. Salvino, “The opportunity to help develop the only high-acuity trauma program in western region of Metro-Phoenix to the California border and to help integrate the other Abrazo hospitals into our system’s approach to trauma is exciting. West Valley Hospital’s world-class Trauma program will be able to care for the most critically injured trauma patients and I predict we will be very proud of our outcomes as the program launches.”

Dr. Salvino currently serves as the Clinical Assistant Professor for the University of Arizona’s College of Medicine in Tucson. He is also a board member of the Arizona Trauma and Acute Care Consortium (AzTRACC). He is a member of the State Trauma Advisory Board (STAB) serving as co-chair for the workgroup charged with revising the State Trauma Plan. Additionally, Dr. Salvino developed the first formal training course for trauma laparoscopy in the United States as a surgical resident.

molecular

Phoenix Children’s Hospital, TGen create Molecular Medicine Institute

Phoenix Children’s Hospital announced the creation of the Ronald A. Matricaria Institute of Molecular Medicine Tuesday, in a joint venture with The Translational Genomics Research Institute (TGen) and The University of Arizona’s College of Medicine.

The three organizations are joining forces with the hopes of unlocking genetic codes in child, adolescent and young adult cancer patients and develop drug therapies in real time to improve the outcome and treatment in these young demographics.

“Our goal is to bring genomics to the forefront of pediatrics,” said Robert L. Meyer, Phoenix Children’s president and CEO. “Research and development of novel treatments for pediatric diseases has fallen short over past decades.”

The reason why the Ronald A. Matricaria Institute of Molecular Medicine is focusing on young patients is because there have been hardly any new therapies introduced to this population in the past two decades. The new institute hopes that clinical studies on children will lead to a better understanding of specific differences between children and adults, which will hopefully lead to the development of safer, more effective and more age-appropriate drug treatments that can be provided in a faster amount of time.

“A challenge with existing molecular medicine programs is the amount of time it takes to develop a new drug or treatment,” Meyer said. “Our collaboration with TGen and University of Arizona opens the doors to making a portfolio of drugs and compounds available immediately.”

The institute will also focus their clinical studies based on underlying genetic and molecular functions of different pediatric cancers, rather than specifically on tumor type. Furthermore, physicians will then create various treatment plans specifically for each patient treated based on the drug therapy that will attack and correct the malfunctioning genes.

With the start of the new institute, a special team of physician scientists will be brought on board to help start out the genomic profiling: Dr. Timothy Triche, a pediatric pathologist and former director of the Center for Personalized Medicine at Children’s Hospital in Los Angeles; Dr. Robert Arceci, a pediatric oncologist from Johns Hopkins University; and Dr. Daniel D. Von Hoff, a medical oncologist at TGen.

“We are trying to figure out a way to have children get appropriate drugs,” said Dr. Robert Arceci. “We all want to know what causes diseases and how we can treat them and I think it takes a special team of people to do this and it takes a lot of unselfish commitment.”

A founding member from whom the institute gets its name, Ronald A. Matricaria, a member of the board of directors for the Phoenix Children’s Hospital, is excited and hopeful for what the new institute is capable of doing in the world of pediatric care.

“Based on my knowledge of the institute and many years of working in the medical field, I’m confident that we can chart a new course for addressing the unique needs of children with cancer and other life-threatening diseases,” Matricaria said. “We could have a huge impact on children’s live and what could be better than that.

 

Concord Eastridge

Concord Eastridge: Downtown Phoenix's Newest Residential Housing Project

A new residential housing project will take over one of Phoenix’s most visible vacant lots in downtown to construct the two-building project of Concord Eastridge.

Sitting on 2.89 acres of vacant land in the Evans Churchill neighborhood of downtown Phoenix, Concord Eastridge will meet the demands of students and young professionals seeking an urban lifestyle. The two-building project is the first of its kind supporting downtown student housing for the growing education sector of Arizona State University’s downtown campus, University of Arizona’s College of Medicine and the Phoenix Biomedical Campus.

The project, designed to be an attractive option for upper level students, new graduates and young adults within the community will boast approximately 325 apartment units and 5,000 square feet of retail space. The project on its own is being recognized for the positive impact it will have for the downtown Phoenix economy as the newest housing addition to the Roosevelt Row area.

Join Phoenix Mayor Greg Stanton, Concord Eastridge CEO Susan Eastridge and financing partner Tom Trubiana of EdR, Tuesday, March 6, 2012 for the groundbreaking of the ceremony at 10 a.m. at the Southwest corner of Fourth Street and Garfield in downtown Phoenix.

To learn more about the new project, visit concordeastridge.com